153 related articles for article (PubMed ID: 37993419)
1. USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway.
Wang L; Wang J; Ma X; Ju G; Shi C; Wang W; Wu J
Cell Death Discov; 2023 Nov; 9(1):421. PubMed ID: 37993419
[TBL] [Abstract][Full Text] [Related]
2. USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation.
Lv T; Zhang B; Jiang C; Zeng Q; Yang J; Zhou Y
Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594129
[TBL] [Abstract][Full Text] [Related]
3. LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.
Liang C; Pang L; Ke Y; Ji W; Xiong J; Ding R; Ding Y
Int J Clin Exp Pathol; 2019; 12(11):4011-4023. PubMed ID: 31933797
[TBL] [Abstract][Full Text] [Related]
4. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α.
Cao J; Wu D; Wu G; Wang Y; Ren T; Wang Y; Lv Y; Sun W; Wang J; Qian C; He L; Yang K; Li H; Gu H
Cell Death Dis; 2021 Jun; 12(6):619. PubMed ID: 34131114
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific Protease 35 Promotes Gastric Cancer Metastasis by Increasing the Stability of Snail1.
Ma C; Tian Z; Wang D; Gao W; Qian L; Zang Y; Xu X; Jia J; Liu Z
Int J Biol Sci; 2024; 20(3):953-967. PubMed ID: 38250150
[TBL] [Abstract][Full Text] [Related]
7. VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.
Pu Z; Duda DG; Zhu Y; Pei S; Wang X; Huang Y; Yi P; Huang Z; Peng F; Hu X; Fan X
J Transl Med; 2022 May; 20(1):212. PubMed ID: 35562734
[TBL] [Abstract][Full Text] [Related]
8. Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma.
Huang G; Yang Y; Lv M; Huang T; Zhan X; Kang W; Hou J
Onco Targets Ther; 2020; 13():9759-9770. PubMed ID: 33061455
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma.
Wang S; Wang T; Zhang X; Cheng S; Chen C; Yang G; Wang F; Wang R; Zhang Q; Yang D; Zhang Y; Liu S; Qin H; Liu Q; Liu H
Cell Death Differ; 2023 Jul; 30(7):1757-1770. PubMed ID: 37173391
[TBL] [Abstract][Full Text] [Related]
10. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
11. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway.
Shen Q; Jiang S; Wu M; Zhang L; Su X; Zhao D
Cancer Manag Res; 2020; 12():6585-6595. PubMed ID: 32821157
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.
Liu C; Chen Z; Ding X; Qiao Y; Li B
Lab Invest; 2022 May; 102(5):524-533. PubMed ID: 35022505
[TBL] [Abstract][Full Text] [Related]
14. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
15. Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K/AKT/mTOR signaling pathway.
Song Q; Zhang H; He J; Kong H; Tao R; Huang Y; Yu H; Zhang Z; Huang Z; Wei L; Liu C; Wang L; Ning Q; Huang J
Ther Adv Med Oncol; 2020; 12():1758835920937890. PubMed ID: 32922520
[TBL] [Abstract][Full Text] [Related]
16. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
Lv B; Liu X; Zhu X; Huang M
World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254
[TBL] [Abstract][Full Text] [Related]
17. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
18. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
19. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
Zheng YF; Zhang XY; Bu YZ
J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306
[TBL] [Abstract][Full Text] [Related]
20. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
